Cargando…
COVID-19: an Immunopathological View
Since its emergence in December 2019, it took only a couple of months for an outbreak of the novel coronavirus disease 2019 (COVID-19) to be declared a pandemic by the World Health Organization (WHO). This along with the highly infectious nature of the disease and the associated mortality call for p...
Autor principal: | Kadkhoda, Kamran |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society for Microbiology
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7178552/ https://www.ncbi.nlm.nih.gov/pubmed/32321823 http://dx.doi.org/10.1128/mSphere.00344-20 |
Ejemplares similares
-
Post-COVID mRNA-vaccine IgG4 shift: worrisome?
por: Kadkhoda, Kamran
Publicado: (2023) -
Consequences of immunopathology for pathogen virulence evolution and public health: malaria as a case study
por: Long, Gráinne H, et al.
Publicado: (2011) -
Immunopathology of Hyperinflammation in COVID-19
por: Gustine, Joshua N., et al.
Publicado: (2021) -
Letter to the editor: COVID-19: how accurate are seroprevalence studies?
por: Kadkhoda, Kamran
Publicado: (2020) -
Immune dysregulation and immunopathology induced by SARS-CoV-2 and related coronaviruses — are we our own worst enemy?
por: Wong, Lok-Yin Roy, et al.
Publicado: (2021)